JP2014098037A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014098037A5 JP2014098037A5 JP2014037949A JP2014037949A JP2014098037A5 JP 2014098037 A5 JP2014098037 A5 JP 2014098037A5 JP 2014037949 A JP2014037949 A JP 2014037949A JP 2014037949 A JP2014037949 A JP 2014037949A JP 2014098037 A5 JP2014098037 A5 JP 2014098037A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- infection
- tissue
- sodium
- dichlorotaurine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000009472 formulation Methods 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 13
- 206010057190 Respiratory tract infections Diseases 0.000 claims 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 3
- 229910052708 sodium Inorganic materials 0.000 claims 3
- 239000011734 sodium Substances 0.000 claims 3
- 235000017281 sodium acetate Nutrition 0.000 claims 3
- 239000001632 sodium acetate Substances 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 2
- 206010058803 Oesophageal infection Diseases 0.000 claims 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 claims 1
- 230000000249 desinfective effect Effects 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims 1
Claims (6)
- ２，２−ジメチル−Ｎ，Ｎ−ジクロロタウリンナトリウムおよび酢酸ナトリウムを含む、感染組織を処置するための処方物であって、該処方物のｐＨは４．０〜５．５である、処方物。
- 前記組織が、眼、耳、鼻、副鼻腔または皮膚組織である、請求項１に記載の処方物。
- 前記処方物が二液性処方物である、請求項１に記載の処方物。
- ２，２−ジメチル−Ｎ，Ｎ−ジクロロタウリンナトリウムおよび酢酸ナトリウムを含む、呼吸器感染症を処置するための処方物であって、該処方物のｐＨは４．０〜５．５である、処方物。
- 前記呼吸器の感染が、
副鼻腔組織感染、鼻感染、上部呼吸器感染、肺／下部呼吸器感染、食道感染およびそれらの組合せからなる群から選択される、請求項４に記載の処方物。 - ２，２−ジメチル−Ｎ，Ｎ−ジクロロタウリンナトリウムおよび酢酸ナトリウムを含む表面を消毒するための処方物であって、該表面が体組織であり、該処方物のｐＨは４．０〜５．５である、処方物。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91527107P | 2007-05-01 | 2007-05-01 | |
| US60/915,271 | 2007-05-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506585A Division JP2010526084A (ja) | 2007-05-01 | 2008-04-30 | Ｎ−ハロゲン化アミノ酸処方物を含む脂肪族系酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014098037A JP2014098037A (ja) | 2014-05-29 |
| JP2014098037A5 true JP2014098037A5 (ja) | 2014-08-07 |
Family
ID=39616420
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506585A Withdrawn JP2010526084A (ja) | 2007-05-01 | 2008-04-30 | Ｎ−ハロゲン化アミノ酸処方物を含む脂肪族系酸 |
| JP2014037949A Withdrawn JP2014098037A (ja) | 2007-05-01 | 2014-02-28 | Ｎ−ハロゲン化アミノ酸処方物を含む脂肪族系酸 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506585A Withdrawn JP2010526084A (ja) | 2007-05-01 | 2008-04-30 | Ｎ−ハロゲン化アミノ酸処方物を含む脂肪族系酸 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20080275126A1 (ja) |
| EP (1) | EP2139520B1 (ja) |
| JP (2) | JP2010526084A (ja) |
| KR (1) | KR20100017156A (ja) |
| CN (1) | CN101678105A (ja) |
| AR (1) | AR066371A1 (ja) |
| AU (1) | AU2008245460B2 (ja) |
| BR (1) | BRPI0811073A2 (ja) |
| CA (1) | CA2684101A1 (ja) |
| CL (1) | CL2008001283A1 (ja) |
| ES (1) | ES2432408T3 (ja) |
| MX (1) | MX2009011817A (ja) |
| RU (1) | RU2009144291A (ja) |
| TW (1) | TW200902092A (ja) |
| UY (1) | UY31057A1 (ja) |
| WO (1) | WO2008134692A1 (ja) |
| ZA (1) | ZA200907052B (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110151025A1 (en) * | 2008-04-10 | 2011-06-23 | Novabay Pharmaceuticals, Inc. | Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections |
| US20110091570A1 (en) * | 2008-04-15 | 2011-04-21 | Waldemar Gottardi | Compositions and Devices for Antisepsis and Anticoagulation |
| CN113729039A (zh) * | 2021-08-27 | 2021-12-03 | 上海罗克环控节能科技股份有限公司 | 一种绿色环保消毒液及其制造方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6027965B2 (ja) * | 1980-02-23 | 1985-07-02 | 東洋コンタクトレンズ株式会社 | コンタクトレンズに付着した汚れの除去方法 |
| US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
| AU3070395A (en) * | 1994-07-22 | 1996-02-22 | Alcon Laboratories, Inc. | Use of low molecular weight amino acids in ophthalmic compositions |
| US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| US6387427B1 (en) * | 2000-09-28 | 2002-05-14 | Nestec S.A. | Method of preservation of a food product |
| EP1469860A4 (en) * | 2002-01-24 | 2005-09-07 | Yissum Res Dev Co | ANTICANCER COMBINATION AND USE THEREOF |
| SI1656095T1 (sl) * | 2003-08-18 | 2014-04-30 | Nobabay Pharmaceuticals, Inc. | N,n-dihalogenirane aminokisline in derivati |
| TWI386201B (zh) * | 2005-01-25 | 2013-02-21 | Novabay Pharmaceuticals Inc | Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法 |
| EP1948154A1 (en) * | 2005-10-06 | 2008-07-30 | Novabay Pharmaceuticals, Inc. | System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
-
2008
- 2008-04-29 UY UY31057A patent/UY31057A1/es unknown
- 2008-04-30 TW TW097115864A patent/TW200902092A/zh unknown
- 2008-04-30 EP EP08795826.0A patent/EP2139520B1/en not_active Not-in-force
- 2008-04-30 CN CN200880014268A patent/CN101678105A/zh active Pending
- 2008-04-30 MX MX2009011817A patent/MX2009011817A/es not_active Application Discontinuation
- 2008-04-30 US US12/112,370 patent/US20080275126A1/en not_active Abandoned
- 2008-04-30 CA CA002684101A patent/CA2684101A1/en not_active Abandoned
- 2008-04-30 AU AU2008245460A patent/AU2008245460B2/en not_active Ceased
- 2008-04-30 JP JP2010506585A patent/JP2010526084A/ja not_active Withdrawn
- 2008-04-30 AR ARP080101842A patent/AR066371A1/es unknown
- 2008-04-30 RU RU2009144291/15A patent/RU2009144291A/ru not_active Application Discontinuation
- 2008-04-30 WO PCT/US2008/061950 patent/WO2008134692A1/en active Application Filing
- 2008-04-30 KR KR1020097024156A patent/KR20100017156A/ko not_active Application Discontinuation
- 2008-04-30 ES ES08795826T patent/ES2432408T3/es active Active
- 2008-04-30 BR BRPI0811073-5A2A patent/BRPI0811073A2/pt not_active IP Right Cessation
- 2008-05-02 CL CL2008001283A patent/CL2008001283A1/es unknown
-
2009
- 2009-10-09 ZA ZA2009/07052A patent/ZA200907052B/en unknown
-
2010
- 2010-11-16 US US12/947,740 patent/US20110060044A1/en not_active Abandoned
-
2014
- 2014-02-28 JP JP2014037949A patent/JP2014098037A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE056471T2 (hu) | Dalargin akut légzõszervi vírusos fertõzések kezelésében történõ alkalmazásra | |
| WO2016198531A3 (en) | Hpv vaccines | |
| EP3675719A4 (en) | USE OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY DISORDER | |
| JP2016529417A5 (ja) | ||
| JP2011516477A5 (ja) | ||
| PH12017502087B1 (en) | Tiotropium inhalation solution for nebulization | |
| IL266619A (en) | Treatment of diseases and infections of the respiratory tract with ascorbic acid preparations | |
| PT3307293T (pt) | Formulações para o tratamento de distúrbios da boca, garganta e trato respiratório | |
| JP2014098037A5 (ja) | ||
| IL283469A (en) | Inhalable preparations for use in the treatment of lung diseases | |
| EA201592298A1 (ru) | Полуживая вирусная вакцина против респираторно-синцитиального вируса | |
| EP3458045A4 (en) | TREATMENT OF MÉNIÈRE'S DISEASE | |
| EP3656407A4 (en) | DEVICE FOR THE PRESERVATIVE TREATMENT OF NASAL AND PARANASAL SINUS DISEASES | |
| EA201592299A1 (ru) | Полуживая вирусная вакцина против респираторно-синцитиального вируса | |
| JP2012508693A5 (ja) | ||
| WO2015165964A8 (en) | Treatment and prevention of alzheimer's disease (ad) | |
| WO2018085516A3 (en) | Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases | |
| JP2015508052A5 (ja) | ||
| JP2019074725A5 (ja) | ||
| NZ740722A (en) | Oral suspension for treating eosinophilic esophagitis | |
| TWD193472S (zh) | sprayer | |
| AU2017901180A0 (en) | Treatment of respiratory infection | |
| EP3943110C0 (en) | USE OF PHOTOSENSITIZERS TO TREAT VIRAL RESPIRATORY INFECTIONS | |
| WO2018084817A3 (en) | A new form of active agent | |
| PL405042A1 (pl) | Preparat wspomagający leczenie schorzeń górnych dróg oddechowych i wzmacniający naturalną odporność organizmu |